GLP1R and type 2 diabetes mellitus: Further study has suggested that a specific set of gut microbiota in the ileum impair the GLP-1-mediated gut–brain axis controlling insulin secretion and gastric emptying, indicating that GLP-1RAs will not work in all T2DM patients and must be discontinued in those patients with altered microbiota and enteric neuron-mediated nitric oxide (NO.